2-[3-[(2,6-Dimethylphenyl)methoxy]-4-(hydroxymethyl)phenyl]-2-oxoacetic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-[3-[(2,6-Dimethylphenyl)methoxy]-4-(hydroxymethyl)phenyl]-2-oxoacetic acid
• 英文别名: 2-[3-[(2,6-dimethylphenyl)methoxy]-4-(hydroxymethyl)phenyl]-2-oxoacetic acid
• 化学式: C₁₈H₁₈O₅
• 分子量: 314.3
• InChiKey: OSZQYHBUBNQETO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• 3-Benzyloxyphenyloxoacetic Acid Compounds for Reducing Uric Acid
  申请人：Sharma Shalini

  公开号：US20140142185A1

  公开（公告）日：2014-05-22

  Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula (I) or its pharmaceutically acceptable salts. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including gout, hyperuricemia, elevated levels of uric acid that do not meet the levels customarily justifying a diagnosis of hyperuricemia, renal dysfunction, kidney stones, cardiovascular disease, risk for developing cardiovascular disease, tumor-lysis syndrome, cognitive impairment, early-onset essential hypertension, and Plasmodium falciparum -induced inflammation. R 1 is hydrogen or alkyl having from 1 to 3 carbon atoms. R 2 is alkyl having from 1 to 3 carbon atoms, alkoxy having from 1 to 3 carbon atoms, hydroxy, nitro, halo, thio, alkylthio, or cyano. R 3 and R 4 are each independently hydrogen, methyl, ethyl, perfluoromethyl, methoxy, ethoxy, perfluoromethoxy, halo, hydroxy, nitro, or amino.

  在哺乳动物主体中，通过给予式(I)化合物或其药学上可接受的盐，可以降低尿酸并增加尿酸的排泄。本发明化合物的降尿酸作用可用于治疗或预防多种疾病，包括痛风、高尿酸血症、尿酸水平升高但不符合通常诊断为高尿酸血症的水平、肾功能障碍、肾结石、心血管疾病、患心血管疾病的风险、肿瘤溶解综合症、认知障碍、早发性高血压和疟原虫引起的炎症。其中，R1为氢或具有1至3个碳原子的烷基；R2为具有1至3个碳原子的烷基、具有1至3个碳原子的烷氧基、羟基、硝基、卤素、硫、烷硫基或氰基；R3和R4各自独立地为氢、甲基、乙基、全氟甲基、甲氧基、乙氧基、全氟甲氧基、卤素、羟基、硝基或氨基。